Beyond Pharmaceuticals: Fit-for-Purpose New Approach Methodologies for Environmental Cardiotoxicity Testing

被引:9
|
作者
Daley, Mark C. [1 ,2 ]
Mende, Ulrike [3 ,4 ]
Choi, Bum-Rak [3 ,4 ]
McMullen, Patrick D. [5 ]
Coulombe, Kareen L. K. [1 ,2 ,6 ]
机构
[1] Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI USA
[2] Brown Univ, Div Biol & Med, Providence, RI USA
[3] Brown Univ, Rhode Isl Hosp, Cardiovasc Inst, Cardiovasc Res Ctr, Providence, RI USA
[4] Brown Univ, Warren Alpert Med Sch, Providence, RI USA
[5] ScitoVation, Durham, NC USA
[6] Brown Univ, Ctr Biomed Engn, Sch Engn, 184 Hope St,Box D, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
CELL-DERIVED CARDIOMYOCYTES; PLURIPOTENT STEM-CELLS; IN-VIVO EXTRAPOLATION; RISK-ASSESSMENT; DRUG DISCOVERY; VITRO; TOXICITY; SAFETY; HEART; OPPORTUNITIES;
D O I
10.14573/altex.2109131
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Environmental factors play a substantial role in determining cardiovascular health, but data informing the risks presented by environmental toxicants is insufficient. In vitro new approach methodologies (NAMs) offer a promising approach with which to address the limitations of traditional in vivo and in vitro assays for assessing cardiotoxicity. Driven largely by the needs of pharmaceutical toxicity testing, considerable progress in developing NAMs for cardiotoxicity analysis has already been made. As the scientific and regulatory interest in NAMs for environmental chemicals continues to grow, a thorough under-standing of the unique features of environmental cardiotoxicants and their associated cardiotoxicities is needed. Here, we review the key characteristics of as well as important regulatory and biological considerations for fit-for-purpose NAMs for environmental cardiotoxicity. By emphasizing the challenges and opportunities presented by NAMs for environmental car-diotoxicity we hope to accelerate their development, acceptance, and application.
引用
下载
收藏
页码:103 / 116
页数:14
相关论文
共 50 条
  • [31] Can user testing of a clinical trial patient information sheet make it fit-for-purpose? - a randomized controlled trial
    Knapp, Peter
    Raynor, David K.
    Silcock, Jonathan
    Parkinson, Brian
    BMC MEDICINE, 2011, 9
  • [32] Ten principles for generating accessible and useable COVID-19 environmental science and a fit-for-purpose evidence base
    Kadykalo, Andrew N.
    Haddaway, Neal R.
    Rytwinski, Trina
    Cooke, Steven J.
    ECOLOGICAL SOLUTIONS AND EVIDENCE, 2021, 2 (01):
  • [33] 'Fit-for-Purpose' sustainability index: a simplified approach for U.S. water utility sustainability assessment
    Ries, M.
    Trotz, M.
    Vairavamoorthy, K.
    WATER PRACTICE AND TECHNOLOGY, 2016, 11 (01): : 35 - 47
  • [34] The testing approach for the Environmental Risk Assessment (ERA) of pharmaceuticals
    Conto, Antonio
    CHIMICA OGGI-CHEMISTRY TODAY, 2012, 30 (03) : 48 - 52
  • [35] Designing fit-for-purpose indicators to connect nature and people's well-being in New Zealand
    Ausseil, Anne-Gaelle Elsa
    Booth, Pamela
    Greenhalgh, Suzie
    Samarasinghe, Oshadhi
    Collins, Alison
    FRONTIERS IN ENVIRONMENTAL SCIENCE, 2023, 11
  • [36] Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1
    Leyre Echeazarra
    Gontzal García del Caño
    Sergio Barrondo
    Imanol González-Burguera
    Miquel Saumell-Esnaola
    Xabier Aretxabala
    Maider López de Jesús
    Leire Borrega-Román
    Susana Mato
    Catherine Ledent
    Carlos Matute
    María Aranzazu Goicolea
    Joan Sallés
    Histochemistry and Cell Biology, 2021, 156 : 479 - 502
  • [37] Spatial aspect of fit-for-purpose land administration for emerging land administration systems: a conceptual framework for evaluation approach
    Rugema, Didier Milindi
    Birhanu, Tadesse Amsalu
    Shibeshi, Gebeyehu Belay
    SURVEY REVIEW, 2022, 54 (382) : 79 - 92
  • [38] Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1
    Echeazarra, Leyre
    Garcia del Cano, Gontzal
    Barrondo, Sergio
    Gonzalez-Burguera, Imanol
    Saumell-Esnaola, Miquel
    Aretxabala, Xabier
    Lopez de Jesus, Maider
    Borrega-Roman, Leire
    Mato, Susana
    Ledent, Catherine
    Matute, Carlos
    Goicolea, Maria Aranzazu
    Salles, Joan
    HISTOCHEMISTRY AND CELL BIOLOGY, 2021, 156 (05) : 479 - 502
  • [39] Do Design Science Research and Design Thinking Processes Improve the 'Fit' of the Fit-For-Purpose Approach to Securing Land Tenure for All in South Africa?
    Hull, Simon
    Whittal, Jennifer
    LAND, 2021, 10 (05)
  • [40] FDA Guidance on Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments: Old Wine in a New Bottle?
    Ari Gnanasakthy
    Shanshan Qin
    Lindsey Norcross
    The Patient - Patient-Centered Outcomes Research, 2023, 16 : 3 - 5